[{"data":1,"prerenderedAt":186},["ShallowReactive",2],{"drug-ipv-vaccine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":23,"regimens":37,"contraindications":81,"warnings":91,"renal":92,"monitoring":93,"interactions":94,"review":95,"examples":98,"atc":109,"iran":111,"links":139,"populations":154,"usApproval":181},"ipv-vaccine",1,{"fa":7,"en":8},"واکسن فلج اطفال تزریقی (IPV)","Inactivated polio vaccine (IPV)","anti-infectives",{"fa":11,"en":12},"واکسن غیرفعال","Inactivated vaccine",[14],{"name":15,"market":16},"IPOL","US",[18,19,20,21,22],"ipol","IPV","واکسن فلج اطفال","پولیو","polio",[24],{"id":25,"form":26,"route":27,"label":28,"concentration":29,"markets":32,"refs":33},"syr-05","injection","im","0.5 mL dose",{"amount":30,"unit":31,"perVolumeMl":30},0.5,"mL",[16],[34],{"source":35,"section":36},"fda-ipol","Dosage and Administration",[38,63],{"id":39,"disease":40,"label":41,"population":44,"type":51,"unit":31,"dose":52,"refs":53,"durationDays":55,"notes":56},"child","immunization",{"fa":42,"en":43},"کودک — سری اولیه ۳ دوز ۰٫۵ mL (۲، ۴ و ۶ تا ۱۸ ماهگی) و یادآور ۴ تا ۶ سالگی","Children — primary 3 × 0.5 mL (2, 4 and 6–18 months) and a booster at 4–6 y",{"minAge":45,"maxAge":48},{"value":46,"unit":47},6,"week",{"value":49,"unit":50},18,"year","fixed",{"perDose":30,"dosesPerDay":5},[54],{"source":35,"section":36},{"min":5,"max":5},[57],{"text":58,"refs":61},{"fa":59,"en":60},"عضلانی یا زیرجلدی؛ ترجیحاً با فاصله ۸ هفته یا بیشتر و هرگز کمتر از ۴ هفته. در ایران برنامه کشوری را دنبال کنید.","IM or SC; preferably 8 or more weeks apart and never less than 4 weeks. In Iran follow the national schedule.",[62],{"source":35,"section":36},{"id":64,"disease":40,"label":65,"population":68,"type":51,"unit":31,"dose":70,"refs":71,"durationDays":73,"notes":74},"adult",{"fa":66,"en":67},"بزرگسال واکسینه‌نشده در معرض خطر — ۳ دوز ۰٫۵ mL","Unvaccinated adults at risk of exposure — 3 × 0.5 mL",{"minAge":69},{"value":49,"unit":50},{"perDose":30,"dosesPerDay":5},[72],{"source":35,"section":36},{"min":5,"max":5},[75],{"text":76,"refs":79},{"fa":77,"en":78},"دو دوز با فاصله ۱ تا ۲ ماه و دوز سوم ۶ تا ۱۲ ماه بعد (طبق برچسب).","Two doses 1–2 months apart and a third 6–12 months later (per label).",[80],{"source":35,"section":36},[82],{"id":83,"severity":84,"text":85,"refs":88},"allergy","block",{"fa":86,"en":87},"حساسیت به اجزای واکسن از جمله ۲-فنوکسی‌اتانول، فرمالدئید، نئومایسین، استرپتومایسین و پلی‌میکسین B؛ آنافیلاکسی ظرف ۲۴ ساعت پس از دوز قبلی.","Hypersensitivity to vaccine components including 2-phenoxyethanol, formaldehyde, neomycin, streptomycin and polymyxin B; anaphylaxis within 24 h of a previous dose.",[89],{"source":35,"section":90},"Contraindications",[],[],[],[],{"status":96,"reviewer":97,"date":97},"unverified",null,[99,104],{"regimen":39,"formulation":25,"input":100,"expect":103},{"ageMonths":101,"weightKg":102},2,5,{"perDose":30,"mlPerDose":30},{"regimen":64,"formulation":25,"input":105,"expect":108},{"ageYears":106,"weightKg":107},30,70,{"perDose":30,"mlPerDose":30},[110],"J07BF03",{"status":112,"forms":113,"refs":134},"registered",[114,118,122,126,130],{"code":115,"en":116,"fa":117},"14659","VACCINE-POLIOMYELITIS AMP","آمپول واکسن–فلج اطفال",{"code":119,"en":120,"fa":121},"50337","POLIOMYELITIS VACCINE SOLUTION ORAL 20 {dose}","محلول خوراکی واکسن فلج اطفال ۲۰ { دوز }",{"code":123,"en":124,"fa":125},"52281","POLIOMYELITIS VACCINE INJECTION PARENTERAL 5 {dose}","فرآورده تزریقی واکسن فلج اطفال ۵ { دوز }",{"code":127,"en":128,"fa":129},"52956","POLIOMYELITIS VACCINE SUSPENSION ORAL 20 {dose}","سوسپانسیون خوراکی واکسن فلج اطفال ۲۰ { دوز }",{"code":131,"en":132,"fa":133},"52083","POLIOMYELITIS VACCINE INJECTION PARENTERAL 10 {dose}","فرآورده تزریقی واکسن فلج اطفال ۱۰ { دوز }",[135],{"source":136,"section":137,"url":138},"darooyab-generic","G-3499\u002FPoliomyelitis-Vaccines","https:\u002F\u002Fwww.darooyab.ir\u002FG-3499\u002FPoliomyelitis-Vaccines",[140,144,148,151],{"kind":141,"url":142,"label":143},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=103930","BLA103930",{"kind":145,"url":146,"label":147},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=34a647f5-8728-451b-b918-94c8acd15974","FDA IPOL",{"kind":149,"url":150,"label":110},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=J07BF03",{"kind":152,"url":138,"label":153},"darooyab","Poliomyelitis-Vaccines",{"pregnancy":155,"lactation":164,"pediatric":172},{"level":156,"text":157,"quote":160,"refs":161},"caution",{"fa":158,"en":159},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Animal reproduction studies have not been conducted with IPOL vaccine.",[162],{"source":35,"section":163},"PREGNANCY",{"level":156,"text":165,"quote":168,"refs":169},{"fa":166,"en":167},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Because many drugs are excreted in human milk, caution should be exercised when IPOL vaccine is administered to a nursing woman.",[170],{"source":35,"section":171},"NURSING MOTHERS",{"level":173,"text":174,"quote":177,"refs":178},"not-established",{"fa":175,"en":176},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","SAFETY AND EFFECTIVENESS OF IPOL VACCINE IN INFANTS BELOW SIX WEEKS OF AGE HAVE NOT BEEN ESTABLISHED .",[179],{"source":35,"section":180},"PEDIATRIC USE",{"kind":182,"refs":183,"id":143},"BLA",[184],{"source":35,"section":185},"SPL approval \u002F marketing category",1792191874915]